0
Correspondence |

Notice of Incomplete Referencing—Reply

Raymond Voltz, MD
[+] Author Affiliations

Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Neurol. 2009;66(10):1300-1300. doi:10.1001/archneurol.2009.216
Text Size: A A A
Published online

In reply

In the May 2009 issue of the Archives of Neurology, we published a study describing cross-reactive T cells between tumor and nervous system in a patient with a paraneoplastic syndrome.1 This detailed molecular analysis of lymphocytes' T-cell receptor complementarity-determining region 3 sequence was retrieved from this patient's tumor, peripheral blood, and cerebrospinal fluid, describing ontogenetically distinct, but functionally identical, clones in the different tissues.

The cerebrospinal fluid of this patient was also analyzed for MRZ (measles, rubella, zoster) reaction as 1 of a cohort of 76 patients, without specific reference to individual patients.2 The full neurological and oncological details of this patient can now also be found in another article,3 which describes the antibody status in serum and imaging data (fludeoxyglucose [FDG]–PET). This patient is unusual both oncologically (good tumor prognosis of an adult neuroblastoma) and neurologically (long-term survivor of anti-Hu associated paraneoplastic syndrome).

Both articles1 ,3 present completely separate sets of data from separate biological material (represented by, basically, 2 different groups of investigators), albeit from the same patient. By oversight, we did not cross-reference these 2 complementary articles during an essentially parallel review process. As readers may find added value in considering these 2 studies together, we would have loved to do this, and are very grateful for the opportunity to cross-reference them now.

AUTHOR INFORMATION

Correspondence: Dr Voltz, Department of Palliative Medicine, University of Cologne, Kerpener Strasse 62, D-50937 Cologne, Germany (raymond.voltz@uk-koeln.de).

Financial Disclosure: None reported.

REFERENCES

Pellkofer  HL, Voltz  R, Goebels  N, Hohlfeld  R, Dornmair  K. Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue. Arch Neurol 2009;66 (5) 655- 658
PubMed
Jarius  S, Eichhorn  P, Jacobi  C, Wildemann  B, Wick  M, Voltz  R. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity [published online ahead of print November 28, 2008]? J Neurol Sci 2009;280 (1-2) 98- 100
PubMed
Jarius  S, Arnold  S, Linke  R.  et al.  Long term survival in anti-Hu associated adult neuroblastoma [published online May 12, 2009]. J Neurol Sci
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Pellkofer  HL, Voltz  R, Goebels  N, Hohlfeld  R, Dornmair  K. Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue. Arch Neurol 2009;66 (5) 655- 658
PubMed
Jarius  S, Eichhorn  P, Jacobi  C, Wildemann  B, Wick  M, Voltz  R. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity [published online ahead of print November 28, 2008]? J Neurol Sci 2009;280 (1-2) 98- 100
PubMed
Jarius  S, Arnold  S, Linke  R.  et al.  Long term survival in anti-Hu associated adult neuroblastoma [published online May 12, 2009]. J Neurol Sci
PubMed

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics